Carmot has been acquired by Roche in early 2024, making the company a member of the Roche Group.

Making what matters possible.

For people living with obesity and diabetes.

Our Mission

Chemotype Evolution has expanded the universe of therapeutic potential at Carmot.

Our Approach

Life at Carmot

Our driving force is science with a singular focus to improve the lives of people with obesity and diabetes, and to care for one another.

If you are ready to unlock your potential and be a part of this mission, come join us!

Learn More  Open Positions